Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide

Autoimmunity

Volumn 40, Issue 1, 2007, Pages 23-30

  Hrycek, Antoni ^a   Kuśmierz, Dariusz ^a   Dybała, Tomasz ^a   Światkowska, Longina ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

mRNA; Quinagolide; Receptors for TGF ; SLE; TGF 1

Indexed keywords

ANALGESIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; QUINAGOLIDE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; LOW DRUG DOSE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AMINOQUINOLINES; AZATHIOPRINE; CYCLOSPORINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREDNISONE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33847391646     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930601168093     Document Type: Article

References (35)

1. Casali, P. (1990) Polyclonal B cell activation and antigen-driven antibody response as mechanisms of autoantibody production in SLE. Autoimmunity, 5, pp. 147-150.
2. Hrycek, A.,.Kuśmierz, D.,.Mazurek, U. and Wilczok, T. (2005) Human cytomegalovirus in patients with systemic lupus erythematosus. Autoimmunity, 38, pp. 487-491.
3. De Albuquerque, DA,.Ebling, FM,.Lienesch, DW,.Singh, RR and Hahn, BH (2004) Analyses of serum levels of type 1, type 2 and type 3 cytokines reveal multiple abnormalities in lupus-prone (NZB.×.NZW) F1 mice. APLAR J Rheumatol, 7, pp. 3-10.
4. Morimoto, S.,.Tokano, Y.,.Kaneko, H.,.Nozawa, K.,.Amano, H. and Hashimoto, H. (2001) The increased interleukin-13 in patients with systemic lupus erythematosus relations to other Th-1, Th-related cytokines and clinical findings. Autoimmunity, 34, pp. 19-25.
5. Youinou, P. and Corre, R Le (1999) The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus. Lupus, 8, pp. 87-88.
6. Schotte, H.,.Willeke, P.,.Rust, S.,.Assmann, G.,.Domschke, W.,.Gaubitz, M. and Schlüter, B. (2003) The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus, 12, pp. 86-92.
7. Hrycek, A. (1998) Prolactin in immunological processes. Wiad Lek, 51, pp. 226-233.
8. Richards, SM,.Garman, RD,.Keyes, L.,.Kavanagh, B. and McPherson, JM (1998) Prolactin is an antagonist of TGF-β activity and promotes proliferation of murine B cell hybridomas. Cell Immunol, 184, pp. 85-91.
9. Ohtsuka, K.,.Gray, JD,.Stimmler, MM,.Toro, B. and Horwitz, DA (1998) Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J Immunol, 160, pp. 2539-2545.
10. Ohtsuka, K.,.Gray, JD,.Stimmler, MM and Horwitz, DA (1999) The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity. Lupus, 8, pp. 90-94.
11. Lu, L-Y,.Cheng, H-H,.Sung, P-K,.Shiue, J. and Chen, A. (2004) Single-nucleotide polymorphisms of transforming growth factor-beta1 in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect, 37, pp. 145-152.
12. Robak, E.,.Woźniacka, A.,.Sysa-Jedrzejowska, A.,.Stepień, H. and Robak, T. (2001) Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity. Eur Cytokine Netw, 12, pp. 445-452.
13. Hrycek, A.,.Siekiera, U.,.Cieślik, P. and Szkróbka, W. (2005) HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumtol Int, 26, pp. 1-6.
14. Tan, EM,.Cohen, AS,.Fries, JF,.Masi, AT,.Shane, DJ Mc,Rothfield, NF,.Schaller, JG,.Talal, N. and Winclester, RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 25, pp. 1271-1277.
15. Chomczyński, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium-thiocyanate phenol-chloroform extraction. Anal Biochem, 162, pp. 156-159.
16. Woszczyk, D.,.Gola, J.,.Jurzak, M.,.Mazurek, U.,.Mykała-Cieśla, J. and Wilczok, T. (2004) Expression of TGFβ1 genes and their receptor types I, II and III in low- and high-grade malignancy non-Hodgkin's lymphomas. Med Sci Monit, 10, pp. CR33-CR37.
17. Nakajima-Iijima, S.,.Hamada, H.,.Reddy, P. and Kakunaga, T. (1985) Molecular structure of the human cytoplasmic beta-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA, 82, pp. 6133-6137.
18. Derynck, R.,.Jarrett, JA,.Chen, EY,.Eaton, DH,.Bell, JR,.Assoian, RK,.Roberts, AB,.Sporn, MB and Goeddel, DV (1985) Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature, 316, pp. 701-705.
19. Itoh, S.,.Thorikay, M.,.Kowanetz, M.,.Moustakas, A.,.Itoh, F.,.Heldin, CH and Dijke, P ten (2003) Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J Biol Chem, 278, pp. 3751-3761.
20. Lin, HY,.Wang, XF,.Ng-Eaton, E.,.Weinberg, RA and Lodish, HF (1992) Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68, pp. 775-785.
21. Lopez-Casillas, F.,.Cheifetez, S.,.Doody, J.,.Andres, JL,.Lane, WS and Massague, J. (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell, 67, pp. 785-795.
22. Sawicki, F. (1992) Elements of statistics for doctors, Polish Scientific Publishers, Warsaw
23. Letterio, JJ and Bottinger, EP (1998) TGF-β knockout and dominant-negative receptor transgenic mice. Miner Electrolyte Metab, 24, pp. 161-167.
24. Piccirillo, CA,.Chang, Y. and Prud'homme, GJ (1998) TGF-beta 1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J Immunol, 161, pp. 3950-3956.
25. Chu, HW,.Trudeau, JB,.Balzar, S. and Wenzel, SE (2000) Peripheral blood and airway tissue expression of transforming growth factor β by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol, 106, pp. 1115-1123.
26. Sarkar, DK,.Chaturvedi, K.,.Oomizu, S.,.Boyadjieva, NI and Chen, CP (2005) Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-β1, and TGF-β type II receptor interact to inhibit the growth of pituitary lactotropes. Endocrinology, 146, pp. 4179-4188.
27. Rovensky, J.,.Lackovic, V.,.Veselkova, Z.,.Horvathova, M.,.Koska, J.,.Blazickova, S. and Vigas, M. (1999) Plasma cytokine concentration and the cytokine producing ability of whole blood cell cultures from healthy females with pharmacologically induced hyperprolactinemia. Int J Tissue React, 21, pp. 43-49.
28. Correale, J.,.Arias, M. and Gilmore, W. (1998) Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol, 161, pp. 3365-3374.
29. Wickert, L.,.Abiaka, M.,.Bolkenius, U. and Gressner, AM (2004) Corticisteroids stimulate selectively transforming growth factor (TGF)-β receptor type III expression in transdifferentiating hepatic stellate cells. J Hepatol, 40, pp. 69-76.
30. Shi, Y. and Massague, J. (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell, 113, pp. 685-700.
31. Song, S-L,.Gong, Z-J,.Zhang, Q-R and Huang, T-X (2005) Effects of Chinese traditional compound, JinSanE, on expression of TGF-β1 and TGF-β1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. World J Gastroenterol, 11, pp. 2269-2276.
32. Yata, Y.,.Gotwals, Ph,.Koteliansky, V. and Rockey, DC (2002) Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: Implications for antifibrotic therapy. Hepatology, 35, pp. 1022-1030.
33. Chen, Ch,.Wang, X-F and Sun, L. (1997) Expression of transforming growth factor β (TGFβ) type III receptor restores autocrine TGFβ1 activity in human breast cancer MCF-7 cells. Am Soc Biochem Mol Biol, Inc, 272, pp. 12862-12867.
34. Zwaagstra, JC,.Kassam, Z. and O'Connor-McCourt, MD (1999) Down-regulation of transforming growth factor-β receptors: Cooperativity between the types I, II and III receptors and modulation at the cell surface. Exp Cell Res, 252, pp. 352-362.
35. Baek, SS,.Kim, KS,.Nixon, SB,.Wilson, LL and Eling, JE (2001) Cyclooxygenase inhibitors regulate the expression of a TGF beta superfamily member that has proapoptotic and antitumorogenic activities. Mol Pharmacol, 59, pp. 901-908.